東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

FindBook

Google Book

Amazon

博客來

Adherence to Antiretroviral Therapy, Polypharmacy, and Virologic Failure in Women with HIV in the United States : = Retrospective Cohort Analysis.

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Adherence to Antiretroviral Therapy, Polypharmacy, and Virologic Failure in Women with HIV in the United States :/
其他題名:	Retrospective Cohort Analysis.
作者:	Saeed, Abubaker Ibrahim Mohamed.
面頁冊數:	1 online resource (71 pages)
附註:	Source: Masters Abstracts International, Volume: 83-11.
Contained By:	Masters Abstracts International83-11.
標題:	Health sciences. -
電子資源:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=29208460click for full text (PQDT)
ISBN:	9798438736585

Adherence to Antiretroviral Therapy, Polypharmacy, and Virologic Failure in Women with HIV in the United States : = Retrospective Cohort Analysis.
Saeed, Abubaker Ibrahim Mohamed.

Adherence to Antiretroviral Therapy, Polypharmacy, and Virologic Failure in Women with HIV in the United States :Retrospective Cohort Analysis. - 1 online resource (71 pages)

Source: Masters Abstracts International, Volume: 83-11.

Thesis (M.Med.Sc.)--Harvard Medical School, 2022.

Includes bibliographical references

Background: Women with HIV (WHIV) in the United States face many challenges with adherence to antiretroviral drugs and suboptimal adherence often leads to virologic failure.Objectives: The main aim of this study was to identify the association between trajectories of adherence to antiretroviral drugs and time to virologic failure among WHIV.Methods: We conducted a retrospective analysis of longitudinal data among WHIV enrolled in the Women's Interagency HIV Study (WIHS) in the United States from 4/1/2014 to 9/30/2019 (10 consecutive visits). The study included women aged >18 years on antiretroviral therapy (ART) who had at least two consecutive measurements of HIV RNA. Women with less than three measurements of adherence were excluded. Group-based trajectory modeling (GBTM) was used to identify adherence trajectories and Cox proportional hazard regression models were fitted to identify differences in time to virologic failure among adherence trajectories, adjusted for factors potentially influencing the adherence-viral suppression relationship (age, smoking, presence of depression symptoms, alcohol intake at the start of this analysis, drug regimen at the last visit, and frequency of experiencing viremia during the whole study period).Results: A total of 1,437 women were eligible. The median age was 49 (interquartile range 42 - 54) years. The results of GBTM analysis revealed four latent adherence trajectories, namely 'consistently high' (N=378; 26.3%), 'moderate increasing' (N=137; 9.5%), 'moderate decreasing' (N=440; 30.6%), and 'consistently low' (N=482; 33.5%). Virologic failure occurred among 173 (12%) women. Compared to the 'consistently high' trajectory, the adjusted hazard ratio (aHR) for time to virologic failure was higher among patients classified in the 'consistently low' adherence trajectory aHR 2.8 (1.6-4.9; P< 0.001) and decreased proportionally as adherence level increased among other trajectories as follows: 'moderate decreasing' aHR 1.8 (1.02-3.2; P=0.04) and 'moderate increasing' aHR 1.0 (0.4-2.5; P<0.001). Other predictors of virologic failure were current smoking (aAHR 1.5, 1.05-2.2; P=0.02), being on a protease inhibitor-based regimen at the last visit (aHR 2.7,1.8-4.0; P<0.001), being on no therapy at the last visit (aHR 8.8, 5.7-13.3; P<0.001), and frequent presentation with detectable viremia (aHR 2.8, 2.0-4.0; P<0.001).Conclusion: Time to virologic failure was inversely proportional to adherence trajectories. Multilevel targeted behavioral interventions for women with suboptimal adherence are urgently needed. In addition, it is imperative to optimize the drug regimen by selecting potent ART with longer half-lives together with developing anti-smoking campaigns to reduce the risk of inflammation.

Electronic reproduction.
Ann Arbor, Mich. :
ProQuest,
2023

Mode of access: World Wide Web

ISBN: 9798438736585Subjects--Topical Terms:

3168359
Health sciences.
Subjects--Index Terms:

AdherenceIndex Terms--Genre/Form:

542853
Electronic books.

Adherence to Antiretroviral Therapy, Polypharmacy, and Virologic Failure in Women with HIV in the United States : = Retrospective Cohort Analysis.
LDR:04148nmm a2200385K 4500 001 2359779
005 20230917195244.5
006 m o d
007 cr mn ---uuuuu
008 241011s2022 xx obm 000 0 eng d
020 $a 9798438736585
035 $a (MiAaPQ)AAI29208460
035 $a AAI29208460
040 $a MiAaPQ $b eng $c MiAaPQ $d NTU
100 1 $a Saeed, Abubaker Ibrahim Mohamed. $3 3700395
245 1 0 $a Adherence to Antiretroviral Therapy, Polypharmacy, and Virologic Failure in Women with HIV in the United States : $b Retrospective Cohort Analysis.
264 0 $c 2022
300 $a 1 online resource (71 pages)
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
500 $a Source: Masters Abstracts International, Volume: 83-11.
500 $a Advisor: Jacobson, Denise.
502 $a Thesis (M.Med.Sc.)--Harvard Medical School, 2022.
504 $a Includes bibliographical references
520 $a Background: Women with HIV (WHIV) in the United States face many challenges with adherence to antiretroviral drugs and suboptimal adherence often leads to virologic failure.Objectives: The main aim of this study was to identify the association between trajectories of adherence to antiretroviral drugs and time to virologic failure among WHIV.Methods: We conducted a retrospective analysis of longitudinal data among WHIV enrolled in the Women's Interagency HIV Study (WIHS) in the United States from 4/1/2014 to 9/30/2019 (10 consecutive visits). The study included women aged >18 years on antiretroviral therapy (ART) who had at least two consecutive measurements of HIV RNA. Women with less than three measurements of adherence were excluded. Group-based trajectory modeling (GBTM) was used to identify adherence trajectories and Cox proportional hazard regression models were fitted to identify differences in time to virologic failure among adherence trajectories, adjusted for factors potentially influencing the adherence-viral suppression relationship (age, smoking, presence of depression symptoms, alcohol intake at the start of this analysis, drug regimen at the last visit, and frequency of experiencing viremia during the whole study period).Results: A total of 1,437 women were eligible. The median age was 49 (interquartile range 42 - 54) years. The results of GBTM analysis revealed four latent adherence trajectories, namely 'consistently high' (N=378; 26.3%), 'moderate increasing' (N=137; 9.5%), 'moderate decreasing' (N=440; 30.6%), and 'consistently low' (N=482; 33.5%). Virologic failure occurred among 173 (12%) women. Compared to the 'consistently high' trajectory, the adjusted hazard ratio (aHR) for time to virologic failure was higher among patients classified in the 'consistently low' adherence trajectory aHR 2.8 (1.6-4.9; P< 0.001) and decreased proportionally as adherence level increased among other trajectories as follows: 'moderate decreasing' aHR 1.8 (1.02-3.2; P=0.04) and 'moderate increasing' aHR 1.0 (0.4-2.5; P<0.001). Other predictors of virologic failure were current smoking (aAHR 1.5, 1.05-2.2; P=0.02), being on a protease inhibitor-based regimen at the last visit (aHR 2.7,1.8-4.0; P<0.001), being on no therapy at the last visit (aHR 8.8, 5.7-13.3; P<0.001), and frequent presentation with detectable viremia (aHR 2.8, 2.0-4.0; P<0.001).Conclusion: Time to virologic failure was inversely proportional to adherence trajectories. Multilevel targeted behavioral interventions for women with suboptimal adherence are urgently needed. In addition, it is imperative to optimize the drug regimen by selecting potent ART with longer half-lives together with developing anti-smoking campaigns to reduce the risk of inflammation.
533 $a Electronic reproduction. $b Ann Arbor, Mich. : $c ProQuest, $d 2023
538 $a Mode of access: World Wide Web
650 4 $a Health sciences. $3 3168359
653 $a Adherence
653 $a Antiretroviral
653 $a HIV
653 $a Polypharmacy
653 $a Virologic failure
653 $a Women
655 7 $a Electronic books. $2 lcsh $3 542853
690 $a 0566
710 2 $a ProQuest Information and Learning Co. $3 783688
710 2 $a Harvard Medical School. $b Graduate Education. $3 3691726
773 0 $t Masters Abstracts International $g 83-11.
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=29208460 $z click for full text (PQDT)